[시장보고서]세계의 의료용 방사선 차폐 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 소재별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

세계의 의료용 방사선 차폐 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 소재별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Medical Radiation Shielding Market Size, Share & Trends Analysis Report By Product Type (X-ray Shields, MRI Shields), By Material (Lead-based Shielding, Hybrid Shielding), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

상품코드 : 1530119

리서치사 : Grand View Research

발행일 : 2024년 07월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,710,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,174,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,102,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

의료용 방사선 차폐 시장 동향

의료용 방사선 차폐 세계 시장 규모는 2023년에 14억 7,000만 달러로 추정되고, 2024년부터 2030년에 걸쳐 CAGR 6.69%를 나타낼 것으로 예측됩니다. 이 성장의 배경에는 만성 질환의 이환율이 증가하고 이미징이 증가합니다. 암 및 기타 질병 치료에 대한 방사선 치료 및 영상 진단에 대한 수요가 증가함에 따라 환자와 건강 관리 종사자를 유해한 방사선 노출로부터 보호하기 위한 효과적인 방사선 차폐 솔루션의 필요성도 높아질 것으로 예상됩니다. 예를 들어 WHO에 따르면 2022년에는 약 2,000만명이 새롭게 암을 앓고, 약 970만명이 암으로 사망하고 있습니다. 약 5명 중 1명이 평생 암에 걸린다고 보고되었습니다. 게다가, 이미징 및 방사선 치료 장비의 기술 진보도 시장 확대에 기여하고 있으며, 새로운 장비는 좀 더 고급 차폐 소재를 필요로 합니다. 또한 방사선 방호와 관련된 엄격한 정부 규제와 안전 기준이 고급 차폐 솔루션의 채택을 뒷받침하고 있습니다.

정부 및 건강 관리 규제 기관은 의료 시설에서 방사선 안전에 대한 보다 엄격한 지침과 의무화를 실시했습니다. 이러한 규정은 진단 및 치료 중 방사선 노출을 최소화하기 위한 적절한 차폐 대책을 요구합니다. 예를 들어, 미국 원자력 규제 위원회(NRC)는 영상 진단 시 방사선을 차폐하는 물질의 사용을 의무화하는 규제를 실시했습니다. 이는 환자와 의료 종사자를 방사선 노출의 부정적인 영향으로부터 보호하기 때문입니다. 의료용 방사선 차폐 소재나 장치의 기술적 진보가 시장을 크게 견인하고 있습니다. 혁신적이고 무해한 무연 차폐재가 개발되어 기존의 납 기반 솔루션에 비해 특성이 향상되었습니다.

예를 들어, 2022년 12월에 Science Reports에 게재된 논문에 따르면, 폴리머와 텅스텐의 혼합물로부터 나노섬유를 생성하고 모르포 나비의 날개와 유사한 구조의 다층 박막을 만드는 일렉트로 스피닝의 사용으로 새로운 유형의 경량 방사선 방호가 개발되었다는 것입니다. 이 혁신적인 차폐는 종이와 같은 유연한 모양으로 가공되며 두께는 단 0.1mm입니다. 시장은 특히 신흥국 시장에서 건강 관리 인프라의 확대에 의해 견인되고 있습니다. 이 지역에서 건강 관리 인프라의 성장은 새로운 의료 시설에서 방사선 차폐 솔루션의 필요성을 창출하고 있습니다. 또한 양자선 치료와 정위 방사선 수술과 같은 고급 치료법에 최적화된 혁신적인 차폐 소재와 장비 개발은 시장 성장의 유망한 기회가 되고 있습니다.

의료용 방사선 차폐 세계 시장 보고서 구분

이 보고서는 세계, 지역 및 국가 수준에서 수익 성장을 예측하고 2018년부터 2030년까지 각 하위 부문에 대한 최신 산업 동향 분석을 제공합니다. 이 연구에서 Grand View Research는 의료용 방사선 차폐 시장 보고서를 제품 유형, 소재, 용도, 최종 용도 및 지역에 따라 세분화합니다.

제품 유형의 전망(매출액, 2018-2030년)
X선 실드

납 시트와 납 플레이트

납 벽돌

납 커튼

납 유리

납 앞치마

MRI 실드

RF 실드 시스템

자기 차폐 시스템

감마 실드

감마 카메라용 실드

양전자 방사선 단층촬영(PET)용 실드

중성자 차폐

중성자 흡수체

중성자 반사체

소재의 전망(매출액, 2018-2030년)
납 베이스 실드
비연 차폐
하이브리드 차폐
용도의 전망(수익, 2018-2030년)
진단

방사선 촬영(X선)

컴퓨터 단층 촬영(CT)

투시 검사

유방 조영술

치과 영상 진단

치료학

방사선 치료

브라키 테라피

양자선 치료

핵의학

SPECT(단일 광자 방사 단층 촬영법)

양전자 방사선 단층촬영(PET)

최종 용도의 전망(매출액, 2018-2030년)
병원 및 진료소
화상 진단센터
기타 최종 용도
지역별 전망(매출액, 2018-2030년)
북미

미국

캐나다.

멕시코

유럽

독일

영국

프랑스

이탈리아

스페인

덴마크

스웨덴

노르웨이

아시아태평양

중국

일본

인도

한국

호주

태국

라틴아메리카

브라질

아르헨티나

중동 및 아프리카(MEA)

남아프리카

사우디아라비아

쿠웨이트

UAE

기업/경쟁의 분류
벤더 상황
- List of key distributors and channel partners
- Key customers
- Key company market share analysis, 2023
- Amray Group
- ETS-Lindgren
- Gaven Industries
- MarShield
- MAVIG GmbH
- NELCO
- Nuclear Shields BV
- Radiation Protection products, Inc.
- VacuTec MeBtechnik GmbH
- Veritas Medical Solutions

JHS

영문 목차

영문목차

Medical Radiation Shielding Market Trends

The global medical radiation shielding market size was estimated at USD 1.47 billion in 2023 and is expected to grow at a CAGR of 6.69% from 2024 to 2030. This growth can be attributed to the rising incidence of chronic diseases and growing diagnostic imaging procedures. As the demand for radiotherapy and diagnostic imaging in treating cancer and other conditions grows, the need for effective radiation shielding solutions is also expected to increase to protect patients & healthcare workers from harmful radiation exposure. For instance, according to WHO, in 2022, there were around 20 million new cases of cancer and approximately 9.7 million deaths due to the disease. It is reported that about one in five people will develop cancer during their lifetime. Furthermore, technological advancements in imaging equipment and radiotherapy devices contribute to market expansion, as newer machines often require more sophisticated shielding materials. In addition, stringent government regulations and safety standards related to radiation protection propel the adoption of advanced shielding solutions.

Governments and healthcare regulatory agencies are implementing stricter guidelines and mandates for radiation safety in medical facilities. These regulations require adequate shielding measures to minimize radiation exposure during diagnostic and treatment procedures. For instance, the U.S. Nuclear Regulatory Commission (NRC) implemented regulations mandating the application of materials that shield against radiation during diagnostic imaging processes. This is to safeguard patients and healthcare workers from the adverse effects of radiation exposure. Technological advancements in medical radiation shielding materials and equipment are significantly driving the market. Innovative, nontoxic, and lead-free shielding alternatives have been developed that offer improved properties compared to traditional lead-based solutions.

For instance, an article published in Science Reports in December 2022 state that a new type of lightweight radiation protection has been developed through the use of electrospinning, which generates nanofibers from a blend of polymer and tungsten, creating a multilayered thin film similar in structure to the wings of a morpho butterfly. This innovative shield, fashioned into a flexible form similar to paper, measures just 0.1 mm thick. The market is also driven by expanding healthcare infrastructure, especially in developing regions. The growth of healthcare infrastructure in these regions creates a need for radiation-shielding solutions in newly established medical facilities. In addition, developing innovative shielding materials and equipment optimized for advanced treatment modalities, such as proton therapy & stereotactic radiosurgery, presents a promising opportunity for market growth.

Global Medical Radiation Shielding Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the medical radiation shielding market report based on product type, material, application, end-use, and region

Product Type Outlook (Revenue, USD Million, 2018 - 2030)
X-ray Shields

Lead Sheets and Plates

Lead Bricks

Lead Curtains

Lead Glass

Lead Aprons

MRI Shields

RF Shielding Systems

Magnetic Shielding Systems

Gamma Shields

Gamma Camera Shields

Positron Emission Tomography (PET) Shields

Neutron Shields

Neutron Absorbers

Neutron Reflectors

Material Outlook (Revenue, USD Million, 2018 - 2030)
Lead-based Shielding
Non-lead Shielding
Hybrid Shielding
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostics

Radiography (X-ray)

Computed Tomography (CT)

Fluoroscopy

Mammography

Dental Imaging

Therapeutics

Radiotherapy

Brachytherapy

Proton Therapy

Nuclear Medicine

SPECT (Single Photon Emission Computed Tomography)

Positron Emission Tomography (PET)

End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Diagnostic Imaging Centers
Other End-use
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

Kuwait

UAE

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product Type
- 1.2.2. Material
- 1.2.3. Application
- 1.2.4. End-use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Type outlook
- 2.2.2. Material outlook
- 2.2.3. Application Outlook
- 2.2.4. End-use Outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Medical Radiation Shielding Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising incidence of Cancer
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Regulatory standards
  - 3.2.1.4. Growing healthcare expenditure
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High Costs
  - 3.2.2.2. Material handling and disposal
  - 3.2.2.3. Need for customization
3.3. Medical Radiation Shielding Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape
- 3.3.3. Pipeline Analysis

Chapter 4. Medical Radiation Shielding Market: Treatment Estimates & Trend Analysis

4.1. Global Medical Radiation Shielding Market: Product Type Dashboard
4.2. Global Medical Radiation Shielding Market: Product Type Movement Analysis
4.3. Global Medical Radiation Shielding Market by Product Type, Revenue
4.4. X-ray Shields
- 4.4.1. X-ray Shields market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Lead Sheets and Plates
  - 4.4.2.1. Lead Sheets and Plates market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Lead Bricks
  - 4.4.3.1. Lead Bricks market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Lead Curtains
  - 4.4.4.1. Lead Curtains market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.5. Lead Glass
  - 4.4.5.1. Lead Glass market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.6. Lead Aprons
  - 4.4.6.1. Lead Aprons market estimates and forecasts 2018 to 2030 (USD Million)
4.5. MRI Shields
- 4.5.1. MRI Shields market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. RF Shielding Systems
  - 4.5.2.1. RF Shielding Systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Magnetic Shielding Systems
  - 4.5.3.1. Magnetic Shielding Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Gamma Shields
- 4.6.1. Gamma Shields market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.2. Gamma Camera Shields
  - 4.6.2.1. Gamma Camera Shields market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.3. Positron Emission Tomography (PET) Shields
  - 4.6.3.1. Positron Emission Tomography (PET) Shields market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Neutron Shields
- 4.7.1. Neutron Shields market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.2. Neutron Absorbers
  - 4.7.2.1. Neutron Absorbers market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.3. Neutron Reflectors
  - 4.7.3.1. Neutron Reflectors Shields market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Medical Radiation Shielding Market: Material Estimates & Trend Analysis

5.1. Global Medical Radiation Shielding Market: Material Dashboard
5.2. Global Medical Radiation Shielding Market: Material Movement Analysis
5.3. Global Medical Radiation Shielding Market Estimates and Forecasts, By Material, Revenue (USD Million)
5.4. Lead-based Shielding
- 5.4.1. Lead-based Shielding market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Non-lead Shielding
- 5.5.1. Non-lead Shielding market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Hybrid Shielding
- 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Medical Radiation Shielding Market: Application Estimates & Trend Analysis

6.1. Global Medical Radiation Shielding Market: Application Dashboard
6.2. Global Medical Radiation Shielding Market: Application Movement Analysis
6.3. Global Medical Radiation Shielding Market Estimates and Forecasts, by Application, Revenue (USD Million)
6.4. Diagnostics
- 6.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Radiography (X-ray)
  - 6.4.2.1. Radiography (X-ray) market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Computed Tomography (CT)
  - 6.4.3.1. Computed Tomography (CT) market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Fluoroscopy
  - 6.4.4.1. Fluoroscopy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Mammography
  - 6.4.5.1. Mammography market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Dental Imaging
  - 6.4.6.1. Dental Imaging market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Therapeutics
- 6.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. Radiotherapy
  - 6.5.2.1. Radiotherapy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. Brachytherapy
  - 6.5.3.1. Brachytherapy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. Proton Therapy
  - 6.5.4.1. Proton Therapy market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Nuclear Medicine
- 6.6.1. Nuclear Medicine market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. SPECT (Single Photon Emission Computed Tomography)
  - 6.6.2.1. SPECT (Single Photon Emission Computed Tomography) market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. Positron Emission Tomography (PET)
  - 6.6.3.1. Positron Emission Tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Medical Radiation Shielding Market: End Use Estimates & Trend Analysis

7.1. Global Medical Radiation Shielding Market: End-use Dashboard
7.2. Global Medical Radiation Shielding Market: End-use Movement Analysis
7.3. Global Medical Radiation Shielding Market Estimates and Forecasts by End-use, Revenue (USD Million)
7.4. Hospitals & Clinics
- 7.4.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Diagnostic Imaging Centers
- 7.5.1. Diagnostic Imaging Centers market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Other End-use
- 7.6.1. Other End-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Medical Radiation Shielding Market: Regional Estimates & Trend Analysis by Product Type, Material, Application and End-use

8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
- 8.3.1. U.S.
  - 8.3.1.1. Key country dynamics
  - 8.3.1.2. Regulatory framework/ reimbursement structure
  - 8.3.1.3. Competitive scenario
  - 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.2. Canada
  - 8.3.2.1. Key country dynamics
  - 8.3.2.2. Regulatory framework/ reimbursement structure
  - 8.3.2.3. Competitive scenario
  - 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.3. Mexico
  - 8.3.3.1. Key country dynamics
  - 8.3.3.2. Regulatory framework/ reimbursement structure
  - 8.3.3.3. Competitive scenario
  - 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Regulatory framework/ reimbursement structure
  - 8.4.1.3. Competitive scenario
  - 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. Germany
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework/ reimbursement structure
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. France
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework/ reimbursement structure
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.4. Italy
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Regulatory framework/ reimbursement structure
  - 8.4.4.3. Competitive scenario
  - 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.5. Spain
  - 8.4.5.1. Key country dynamics
  - 8.4.5.2. Regulatory framework/ reimbursement structure
  - 8.4.5.3. Competitive scenario
  - 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.6. Norway
  - 8.4.6.1. Key country dynamics
  - 8.4.6.2. Regulatory framework/ reimbursement structure
  - 8.4.6.3. Competitive scenario
  - 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.7. Sweden
  - 8.4.7.1. Key country dynamics
  - 8.4.7.2. Regulatory framework/ reimbursement structure
  - 8.4.7.3. Competitive scenario
  - 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.8. Denmark
  - 8.4.8.1. Key country dynamics
  - 8.4.8.2. Regulatory framework/ reimbursement structure
  - 8.4.8.3. Competitive scenario
  - 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework/ reimbursement structure
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. China
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework/ reimbursement structure
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. India
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework/ reimbursement structure
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. Australia
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework/ reimbursement structure
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. South Korea
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework/ reimbursement structure
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework/ reimbursement structure
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework/reimbursement structure
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Argentina
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework/ reimbursement structure
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework/ reimbursement structure
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework/ reimbursement structure
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework/ reimbursement structure
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Kuwait
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Regulatory framework/ reimbursement structure
  - 8.7.4.3. Competitive scenario
  - 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Vendor Landscape
- 9.2.1. List of key distributors and channel partners
- 9.2.2. Key customers
- 9.2.3. Key company market share analysis, 2023
- 9.2.4. Amray Group
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. ETS-Lindgren
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Gaven Industries
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. MarShield
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. MAVIG GmbH
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. NELCO
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Nuclear Shields B.V.
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives
- 9.2.11. Radiation Protection products, Inc.
  - 9.2.11.1. Company overview
  - 9.2.11.2. Financial performance
  - 9.2.11.3. Product benchmarking
  - 9.2.11.4. Strategic initiatives
- 9.2.12 VacuTec MeBtechnik GmbH
  - 9.2.12.1 Company overview
  - 9.2.12.2 Financial performance
  - 9.2.12.3 Product benchmarking
  - 9.2.12.4 Strategic initiatives
- 9.2.13 Veritas Medical Solutions
  - 9.2.13.1 Company overview
  - 9.2.13.2 Financial performance
  - 9.2.13.3 Product benchmarking
  - 9.2.13.4 Strategic initiatives

한글목차

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 방사선 차폐 시장의 변수, 동향, 범위

제4장 의료용 방사선 차폐 시장 :치료 추정·동향 분석

제5장 의료용 방사선 차폐 시장 :소재 추정·동향 분석

제6장 의료용 방사선 차폐 시장 : 용도 추정·동향 분석

제7장 의료용 방사선 차폐 시장 : 최종 용도의 추정·동향 분석

제8장 의료용 방사선 차폐 시장 : 제품 유형, 소재, 용도, 최종 용도별 지역 추정·동향 분석

제9장 경쟁 구도